Literature DB >> 14744540

Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1.

Akira Kawai1, Noriko Naito, Aki Yoshida, Yuki Morimoto, Mamoru Ouchida, Kenji Shimizu, Yasuo Beppu.   

Abstract

We describe here the establishment of a new synovial sarcoma cell line, SYO-1, derived from a biphasic synovial sarcoma that developed in the groin of a 19-year-old female. The cell line was maintained for more than 70 passages (more than 24 months) in vitro. The SYO-1 cells in monolayer culture exhibited a spindle shape without conspicuous pleomorphism. Immunohistochemically, the cells were positive for vimentin, type IV collagen, S-100, mdm2, bcl-2, c-Met and c-Kit. Tumors developed by their implantation in nude mice histologically showed biphasic features that were composed of areas of fascicles of spindle cells and areas of compact proliferation of polygonal to ovoid cells, which occasionally formed epithelial plaque and expressed cytokeratin and EMA. SYO-1 cells harbored the characteristic t(X;18)(p11.2;q11.2) translocation by chromosome analysis and SYT-SSX2 chimeric transcript by RT-PCR. The SYO-1 cells, the first characterized cell line derived from biphasic synovial sarcoma retaining the characteristic genetic and phenotypic features of the tumor, will be useful for various investigations on synovial sarcoma, especially for its epithelial differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744540     DOI: 10.1016/j.canlet.2003.09.031

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  48 in total

1.  PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcoma.

Authors:  Alan L Ho; Shyamprasad Deraje Vasudeva; Marick Laé; Tsuyoshi Saito; Violetta Barbashina; Cristina R Antonescu; Marc Ladanyi; Gary K Schwartz
Journal:  Cancer Res       Date:  2012-07-10       Impact factor: 12.701

2.  Characterization of a novel radiation-induced sarcoma cell line.

Authors:  Julie Lang; Weizhu Zhu; Brandon Nokes; Grishma Sheth; Petr Novak; Laura Fuchs; George Watts; Bernard Futscher; Neal Mineyev; Alexander Ring; Lauren LeBeau; Ray Nagle; Lee Cranmer
Journal:  J Surg Oncol       Date:  2015-02-02       Impact factor: 3.454

3.  Cytotoxic effects of zoledronic acid-loaded hydroxyapatite and bone cement in malignant tumors.

Authors:  Kazutaka Koto; Hiroaki Murata; Yasushi Sawai; Eishi Ashihara; Motoyuki Horii; Toshikazu Kubo
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

4.  The effect of SYT-SSX and extracellular signal-regulated kinase (ERK) on cell proliferation in synovial sarcoma.

Authors:  Wenjuan Cai; Yan Sun; Wei Wang; Chunrong Han; Mamoru Ouchida; Wenbin Xia; Xiulan Zhao; Baocun Sun
Journal:  Pathol Oncol Res       Date:  2011-01-14       Impact factor: 3.201

5.  Effect of temozolomide on the viability of musculoskeletal sarcoma cells.

Authors:  Yuta Kusabe; Hiroyuki Kawashima; Akira Ogose; Taro Sasaki; Takashi Ariizumi; Tetsuo Hotta; Naoto Endo
Journal:  Oncol Lett       Date:  2015-07-17       Impact factor: 2.967

6.  The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma.

Authors:  Ana Banito; Xiang Li; Aimée N Laporte; Jae-Seok Roe; Francisco Sanchez-Vega; Chun-Hao Huang; Amanda R Dancsok; Katerina Hatzi; Chi-Chao Chen; Darjus F Tschaharganeh; Rohit Chandwani; Nilgun Tasdemir; Kevin B Jones; Mario R Capecchi; Christopher R Vakoc; Nikolaus Schultz; Marc Ladanyi; Torsten O Nielsen; Scott W Lowe
Journal:  Cancer Cell       Date:  2018-03-01       Impact factor: 31.743

Review 7.  Neuronal differentiation of synovial sarcoma and its therapeutic application.

Authors:  Tatsuya Ishibe; Tomitaka Nakayama; Tomoki Aoyama; Takashi Nakamura; Junya Toguchida
Journal:  Clin Orthop Relat Res       Date:  2008-06-19       Impact factor: 4.176

8.  Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling.

Authors:  Wessen Maruwge; Pádraig D'Arcy; Annika Folin; Slavica Brnjic; Johan Wejde; Anthony Davis; Fredrik Erlandsson; Jonas Bergh; Bertha Brodin
Journal:  Onco Targets Ther       Date:  2008-11-01       Impact factor: 4.147

9.  The Influential Role of BCL2 Family Members in Synovial Sarcomagenesis.

Authors:  Jared J Barrott; Ju-Fen Zhu; Kyllie Smith-Fry; Asia M Susko; Dakota Nollner; Lance D Burrell; Amir Pozner; Mario R Capecchi; Jeffrey T Yap; Lisa A Cannon-Albright; Xingming Deng; Kevin B Jones
Journal:  Mol Cancer Res       Date:  2017-08-29       Impact factor: 5.852

10.  Frequent methylation of RASSF1A in synovial sarcoma and the anti-tumor effects of 5-aza-2'-deoxycytidine against synovial sarcoma cell lines.

Authors:  Kunihiko Numoto; Aki Yoshida; Shinsuke Sugihara; Toshiyuki Kunisada; Yuki Morimoto; Yasushi Yoneda; Yasuko Fujita; Keiichiro Nishida; Mamoru Ouchida; Toshifumi Ozaki
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.